Molecules associated with fatty acid biosynthetic pathways and uses thereof

US10131897B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10131897-B2
Application numberUS-201514637356-A
CountryUS
Kind codeB2
Filing dateMar 3, 2015
Priority dateMar 3, 2014
Publication dateNov 20, 2018
Grant dateNov 20, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates in part to recombinant microorganisms that include non-native genes encoding PUFA-PKS polypeptides, and to methods of making and using such microorganisms for producing at least one PUFA. In particular, the disclosure further relates to methods and related materials useful for the production of at least one PUFA by heterologous expression of the nucleic acid sequences disclosed herein encoding PUFA-PKS polypeptides.

First claim

Opening claim text (preview).

What is claimed is: 1. A recombinant eukaryotic microorganism comprising at least one non-native nucleic acid sequence encoding a prokaryotic Type A polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) system comprising a pfaA gene, a pfaB gene, a pfaC gene, a pfaD gene, and a pfaE gene, wherein the pfaA gene encodes a polypeptide comprises comprising an amino acid sequence having at least 98% identity to SEQ ID NO:2, the pfaB gene encodes a polypeptide comprises comprising an amino acid sequence having at least 96% identity to SEQ ID NO:4, the pfaC gene encodes a polypeptide comprises comprising an amino acid sequence having at least 98% identity to SEQ ID NO:6, the pfaD gene encodes a polypeptide comprises comprising an amino acid sequence having at least 96% identity to SEQ ID NO:8, and the pfaE gene encodes a polypeptide comprises comprising an amino acid sequence having at least 96% identity to SEQ ID NO: 10; wherein the recombinant eukaryotic microorganism produces at least 50% more eicosapentaenoic acid (EPA) than a control eukaryotic microorganism. 2. A recombinant eukaryotic microorganism according to claim 1 , wherein the recombinant eukaryotic microorganism produces at least 75% more EPA than a control eukaryotic microorganism. 3. A recombinant eukaryotic microorganism according to claim 2 , wherein the eukaryotic microorganism produces at least 100% more EPA than a control eukaryotic microorganism. 4. A recombinant eukaryotic microorganism according to claim 1 , wherein the eukaryotic microorganism is a labyrinthulomycete. 5. A recombinant eukaryotic microorganism according to claim 4 , wherein the eukaryotic microorganism is of a genus selected from the group consisting of Aurantiochytrium, Oblongichytrium, Schizochytrium, Thraustochytrium , and Ulkenia. 6. A recombinant eukaryotic microorganism according to claim 1 , wherein the PUFA-PKS system is derived from a prokaryotic species of a genus selected from the group consisting of Shewanella, Vibrio, Aliivibrio, Pseudoaltermonas, Labyrinthuloides , and Psychromonas. 7. A recombinant eukaryotic microorganism according to claim 1 , wherein at least one non-native nucleic acid sequence is operably linked to a heterologous promoter. 8. A method for producing EPA, comprising culturing a recombinant eukaryotic microorganism according to claim 1 to produce EPA. 9. A method according to claim 8 , further comprising recovering EPA from the culture. 10. A method for according to claim 8 , wherein said culturing is performed at a temperature greater than 20° C. 11. A method for according to claim 10 , wherein said culturing is performed at a temperature greater than 25° C. 12. A method for according to claim 11 , wherein said culturing is performed at a temperature of at least 30° C.

Assignees

Inventors

Classifications

  • Ligases forming carbon-carbon bonds (6.4) · CPC title

  • Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone · CPC title

  • transferring groups other than amino-acyl groups (2.3.1) · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

  • C12N9/93Primary

    Ligases (6) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10131897B2 cover?
The present disclosure relates in part to recombinant microorganisms that include non-native genes encoding PUFA-PKS polypeptides, and to methods of making and using such microorganisms for producing at least one PUFA. In particular, the disclosure further relates to methods and related materials useful for the production of at least one PUFA by heterologous expression of the nucleic acid seque…
Who is the assignee on this patent?
Synthetic Genomics Inc, Synthetics Genomics Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/93. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).